1.8M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| John V. W. Reynders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2024 | 10,709 | 10,709 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 11.03 per share. | 07 Oct 2024 | 5,409 | 50,091 | - | 11.0 | 59,661 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 7,151 | 57,242 | - | 0 | Common Stock | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.99 per share. | 04 Oct 2024 | 1,742 | 55,500 | - | 11.0 | 19,145 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 7,151 | 14,303 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Sale of securities on an exchange or to another person at price $ 11.29 per share. | 09 Sep 2024 | 51,224 | 99,704 | - | 11.3 | 578,319 | Common Stock |
| Robert Aspbury | PRESIDENT, SCIENTIFIC SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.85 per share. | 01 Jul 2024 | 862 | 289,314 | - | 13.9 | 11,939 | Common Stock |
| Rona Anhalt | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 21,440 | 21,440 | - | - | Restricted Stock Units | |
| Daniel Corcoran | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 23,822 | 23,822 | - | - | Restricted Stock Units | |
| Daniel Corcoran | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 29,777 | 29,777 | - | - | Restricted Stock Units | |
| Cynthia Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 0 | - | - | Restricted Stock Units | |
| Cynthia Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 24,161 | - | 0 | Common Stock | |
| Cynthia Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Matthew M. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Matthew M. Walsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 185,631 | - | 0 | Common Stock | |
| Matthew M. Walsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 0 | - | - | Restricted Stock Units | |
| Eran Broshy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 23,023 | - | 0 | Common Stock | |
| Eran Broshy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Eran Broshy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 0 | - | - | Restricted Stock Units | |
| James E. Cashman | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| James E. Cashman | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 456,512 | - | 0 | Common Stock | |
| James E. Cashman | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 0 | - | - | Restricted Stock Units | |
| Rosemary A. Crane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Rosemary A. Crane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 17,987 | - | 0 | Common Stock | |
| Rosemary A. Crane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 0 | - | - | Restricted Stock Units | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 11,928 | 11,928 | - | - | Restricted Stock Units | |
| Nancy Killefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 0 | - | - | Restricted Stock Units | |
| Nancy Killefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 8,663 | 24,161 | - | 0 | Common Stock | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 17.77 per share. | 02 Apr 2024 | 422 | 50,091 | - | 17.8 | 7,499 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 16.77 per share. | 02 Apr 2024 | 4,740 | 50,513 | - | 16.8 | 79,490 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 17.67 per share. | 02 Apr 2024 | 328 | 55,253 | - | 17.7 | 5,796 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 16.75 per share. | 02 Apr 2024 | 3,024 | 55,581 | - | 16.8 | 50,652 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 17.72 per share. | 02 Apr 2024 | 649 | 58,605 | - | 17.7 | 11,500 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 16.76 per share. | 02 Apr 2024 | 5,264 | 59,254 | - | 16.8 | 88,225 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 36,580 | 36,580 | - | - | Restricted Stock Units | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 14,115 | 2,249,154 | - | 17.9 | 252,376 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 33,219 | 2,263,269 | - | 0 | Common Stock | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 15,543 | 2,230,050 | - | 17.9 | 277,909 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 36,580 | 2,245,593 | - | 0 | Common Stock | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 12,971 | 2,209,013 | - | 17.9 | 231,921 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 120,981 | 120,981 | - | - | Restricted Stock Units | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 33,219 | 66,440 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 2,106 | 144,988 | - | 17.9 | 37,655 | Common Stock |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 7,852 | 152,840 | - | 0 | Common Stock | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 1,912 | 150,928 | - | 17.9 | 34,187 | Common Stock |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 8,646 | 8,647 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 7,852 | 15,704 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 30,381 | 30,381 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 1,933 | 138,448 | - | 17.9 | 34,562 | Common Stock |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 8,646 | 147,094 | - | 0 | Common Stock | |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 14,663 | 14,663 | - | - | Restricted Stock Units | |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 12,632 | 25,266 | - | - | Restricted Stock Units | |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 45,571 | 45,571 | - | - | Restricted Stock Units | |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 14,663 | 14,663 | - | 0 | Common Stock | |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 4,750 | 9,913 | - | 17.9 | 84,930 | Common Stock |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 12,632 | 22,545 | - | 0 | Common Stock | |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 4,327 | 18,218 | - | 17.9 | 77,367 | Common Stock |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 8,646 | 290,079 | - | 0 | Common Stock | |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 30,381 | 30,381 | - | - | Restricted Stock Units | |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 7,852 | 15,704 | - | - | Restricted Stock Units | |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 8,646 | 8,647 | - | - | Restricted Stock Units | |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 3,691 | 290,176 | - | 17.9 | 65,995 | Common Stock |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 7,852 | 293,867 | - | 0 | Common Stock | |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 2,870 | 281,433 | - | 17.9 | 51,316 | Common Stock |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 4,064 | 286,015 | - | 17.9 | 72,664 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 01 Apr 2024 | 3,000 | 173,524 | - | 18 | 54,000 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 1,723 | 167,750 | - | 17.9 | 30,807 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 6,651 | 174,401 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 2,245 | 172,156 | - | 17.9 | 40,141 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 6,644 | 178,800 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 2,276 | 176,524 | - | 17.9 | 40,695 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 6,651 | 6,651 | - | - | Restricted Stock Units | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 6,644 | 13,288 | - | - | Restricted Stock Units | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 4,228 | 8,456 | - | - | Restricted Stock Units | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,991 | 3,991 | - | - | Restricted Stock Units | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 1,326 | 24,358 | - | 17.9 | 23,709 | Common Stock |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 4,228 | 25,684 | - | 0 | Common Stock | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 1,252 | 21,456 | - | 17.9 | 22,386 | Common Stock |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,991 | 22,708 | - | 0 | Common Stock | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 15,190 | 15,190 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 8,646 | 62,089 | - | 0 | Common Stock | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 7,852 | 67,208 | - | 0 | Common Stock | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 2,690 | 64,518 | - | 17.9 | 48,097 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 8,646 | 8,647 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 7,852 | 15,704 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 30,381 | 30,381 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 1,532 | 53,443 | - | 17.9 | 27,392 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 01 Apr 2024 | 2,733 | 59,356 | - | 17.9 | 48,866 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 124,779 | 124,779 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 05 Mar 2024 | 4,050 | 140,381 | - | 18.9 | 76,464 | Common Stock |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 15,548 | 144,431 | - | 0 | Common Stock | |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 05 Mar 2024 | 1,689 | 284,303 | - | 18.9 | 31,888 | Common Stock |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 11,960 | 288,025 | - | 0 | Common Stock | |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 05 Mar 2024 | 5,622 | 282,403 | - | 18.9 | 106,143 | Common Stock |
| Robert Aspbury | PRESIDENT; SCIENTIFIC SOFTWARE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 3,589 | 285,992 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 05 Mar 2024 | 3,660 | 169,473 | - | 18.9 | 69,101 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 10,765 | 173,133 | - | 0 | Common Stock | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 05 Mar 2024 | 2,373 | 18,717 | - | 18.9 | 44,802 | Common Stock |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 6,600 | 21,090 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 18.28 per share. | 04 Mar 2024 | 3,000 | 162,368 | - | 18.3 | 54,840 | Common Stock |
| Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 20 Feb 2024 | 5,000 | 54,975 | - | 18 | 90,000 | Common Stock |
| Traynor M. Richard | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Feb 2024 | 6,000 | 165,368 | - | 18 | 108,000 | Common Stock |
| M. Traynor Richard | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 26 Dec 2023 | 6,000 | 171,368 | - | 18 | 108,000 | Common Stock |
| Smith F Patrick | PRESIDENT, DRUG DEV SOLUTIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2023 | 21,454 | 21,454 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, CHIEF COMMERCAL OFF | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 11 Sep 2023 | 51,224 | 128,883 | - | 14.6 | 747,870 | Common Stock |
| Eran Broshy | Director | Purchase of securities on an exchange or from another person at price $ 15.80 per share. | 21 Aug 2023 | 4,807 | 14,360 | - | 15.8 | 75,951 | Common Stock |
| Eran Broshy | Director | Purchase of securities on an exchange or from another person at price $ 16.10 per share. | 21 Aug 2023 | 193 | 9,553 | - | 16.1 | 3,107 | Common Stock |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.47 per share. | 01 Aug 2023 | 1,057 | 14,490 | - | 19.5 | 20,580 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.19 per share. | 30 Jun 2023 | 862 | 276,065 | - | 18.2 | 15,680 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 21.55 per share. | 05 Jun 2023 | 19,104 | 59,975 | - | 21.5 | 411,691 | Common Stock |
| Cynthia Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 8,663 | 8,663 | - | - | Restricted Stock Units | |
| Matthew M. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 8,663 | 8,663 | - | - | Restricted Stock Units | |
| Eran Broshy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 9,360 | 9,360 | - | 0 | Common Stock | |
| Eran Broshy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 8,663 | 8,663 | - | - | Restricted Stock Units | |
| Eran Broshy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 9,360 | 0 | - | - | Restricted Stock Units | |
| James E. Cashman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 8,663 | 8,663 | - | - | Restricted Stock Units | |
| Rosemary A. Crane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 9,324 | 9,324 | - | 0 | Common Stock | |
| Rosemary A. Crane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 8,663 | 8,663 | - | - | Restricted Stock Units | |
| Rosemary A. Crane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 9,324 | 0 | - | - | Restricted Stock Units | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 8,663 | 8,663 | - | - | Restricted Stock Units | |
| Cynthia Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 15,498 | - | 0 | Common Stock | |
| Cynthia Collins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 0 | - | - | Restricted Stock Units | |
| Matthew M. Walsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 0 | - | - | Restricted Stock Units | |
| Matthew M. Walsh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 176,968 | - | 0 | Common Stock | |
| James E. Cashman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 447,849 | - | 0 | Common Stock | |
| James E. Cashman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 0 | - | - | Restricted Stock Units | |
| Nancy Killefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 15,498 | - | 0 | Common Stock | |
| Nancy Killefer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 9,067 | 0 | - | - | Restricted Stock Units | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 20.82 per share. | 11 May 2023 | 5,000 | 177,368 | - | 20.8 | 104,100 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 23.66 per share. | 14 Apr 2023 | 5,000 | 182,368 | - | 23.7 | 118,300 | Common Stock |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 37,898 | 37,898 | - | - | Restricted Stock Units | |
| John E. Gallagher | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 29,326 | 29,326 | - | - | Restricted Stock Units | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 99,659 | 99,659 | - | - | Restricted Stock Units | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 36,580 | 73,160 | - | - | Restricted Stock Units | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 15,543 | 2,179,742 | - | 23.8 | 369,923 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 36,580 | 2,195,285 | - | 0 | Common Stock | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 10,091 | 2,158,705 | - | 23.8 | 240,166 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 2,106 | 180,107 | - | 23.8 | 50,123 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 1,933 | 173,567 | - | 23.8 | 46,005 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 8,646 | 17,293 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 23,556 | 23,556 | - | - | Restricted Stock Units | |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 8,646 | 182,213 | - | 0 | Common Stock | |
| Robert Aspbury | PRESIDENT, SIMCYP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 8,646 | 280,991 | - | 0 | Common Stock | |
| Robert Aspbury | PRESIDENT, SIMCYP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 2,870 | 272,345 | - | 23.8 | 68,306 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 4,064 | 276,927 | - | 23.8 | 96,723 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 8,646 | 17,293 | - | - | Restricted Stock Units | |
| Robert Aspbury | PRESIDENT, SIMCYP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 23,556 | 23,556 | - | - | Restricted Stock Units | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 6,651 | 189,492 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 1,723 | 182,841 | - | 23.8 | 41,007 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 19,932 | 19,932 | - | - | Restricted Stock Units | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 6,651 | 13,302 | - | - | Restricted Stock Units | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 2,124 | 187,368 | - | 23.8 | 50,551 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 3,721 | 514,149 | - | 23.8 | 88,560 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 13,302 | 26,604 | - | - | Restricted Stock Units | |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 4,556 | 522,895 | - | 23.8 | 108,433 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 13,302 | 527,451 | - | 0 | Common Stock | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 3,990 | 16,798 | - | 0 | Common Stock | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 12,684 | 12,684 | - | - | Restricted Stock Units | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 3,990 | 7,982 | - | - | Restricted Stock Units | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 1,251 | 15,547 | - | 23.8 | 29,774 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 8,646 | 81,973 | - | 0 | Common Stock | |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 2,894 | 79,079 | - | 23.8 | 68,877 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 1,532 | 73,327 | - | 23.8 | 36,462 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 23,556 | 23,556 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 8,646 | 17,293 | - | - | Restricted Stock Units | |
| Drayton Virkler | PRESIDENT, REG & ACCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 23,556 | 23,556 | - | - | Restricted Stock Units | |
| Drayton Virkler | PRESIDENT, REG & ACCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 3,990 | 7,982 | - | - | Restricted Stock Units | |
| Drayton Virkler | PRESIDENT, REG & ACCES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.80 per share. | 31 Mar 2023 | 1,166 | 12,415 | - | 23.8 | 27,751 | Common Stock |
| Drayton Virkler | PRESIDENT, REG & ACCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 3,990 | 13,581 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 21.45 per share. | 06 Mar 2023 | 10,000 | 184,564 | - | 21.5 | 214,500 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2023 | 59,799 | 2,239,541 | - | 0 | Common Stock | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 05 Mar 2023 | 17,557 | 2,221,984 | - | 18.9 | 331,476 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 02 Feb 2023 | 15,000 | 194,564 | - | 20 | 300,000 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Sale of securities on an exchange or to another person at price $ 15.55 per share. | 22 Nov 2022 | 51,223 | 175,500 | - | 15.6 | 796,518 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 15.57 per share. | 14 Nov 2022 | 245,793 | 660,322 | - | 15.6 | 3,826,997 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 15.27 per share. | 14 Nov 2022 | 4,207 | 906,115 | - | 15.3 | 64,241 | Common Stock |
| Matthew M. Walsh | Director | Sale of securities on an exchange or to another person at price $ 14.74 per share. | 14 Nov 2022 | 12,059 | 167,901 | - | 14.7 | 177,750 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 13.48 per share. | 09 Nov 2022 | 2,387 | 74,859 | - | 13.5 | 32,177 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.23 per share. | 01 Nov 2022 | 1,244 | 77,246 | - | 12.2 | 15,214 | Common Stock |
| Drayton Virkler | INTERIM PRESIDENT, REG & ACCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 17,440 | 17,440 | - | - | Restricted Stock Units | |
| Drayton Virkler | INTERIM PRESIDENT, REG & ACCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 3,021 | 13,595 | - | 0 | Common Stock | |
| Drayton Virkler | INTERIM PRESIDENT, REG & ACCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 3,021 | 6,042 | - | - | Restricted Stock Units | |
| Drayton Virkler | INTERIM PRESIDENT, REG & ACCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 10,574 | 0 | - | - | Restricted Stock Units | |
| Drayton Virkler | INTERIM PRESIDENT, REG & ACCES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 30 Sep 2022 | 4,004 | 9,591 | - | 13.3 | 53,293 | Common stock |
| Drayton Virkler | INTERIM PRESIDENT, REG & ACCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 10,574 | 10,574 | - | 0 | Common Stock | |
| Stephen M. McLean | Director | Purchase of securities on an exchange or from another person at price $ 16.32 per share. | 19 Aug 2022 | 20,000 | 42,000 | - | 16.3 | 326,400 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.64 per share. | 17 Aug 2022 | 25,000 | 517,870 | - | 16.6 | 416,000 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 17.38 per share. | 16 Aug 2022 | 182,475 | 910,322 | - | 17.4 | 3,171,416 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 17.71 per share. | 16 Aug 2022 | 10,000 | 78,490 | - | 17.7 | 177,100 | Common Stock |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.99 per share. | 01 Aug 2022 | 1,755 | 12,808 | - | 23.0 | 40,347 | Common Stock |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.99 per share. | 01 Aug 2022 | 1,057 | 14,563 | - | 23.0 | 24,300 | Common Stock |
| Rosemary A. Crane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 9,324 | 9,324 | - | - | Restricted Stock Units | |
| Eran Broshy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2022 | 9,360 | 9,360 | - | - | Restricted Stock Units | |
| Robert Aspbury | PRESIDENT, SIMCYP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.46 per share. | 01 Jul 2022 | 884 | 275,215 | - | 21.5 | 18,971 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 19.16 per share. | 08 Jun 2022 | 10,000 | 88,490 | - | 19.2 | 191,600 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 19.59 per share. | 02 Jun 2022 | 100,000 | 1,142,797 | - | 19.6 | 1,959,000 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 19.52 per share. | 02 Jun 2022 | 50,000 | 1,092,797 | - | 19.5 | 976,000 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 19.55 per share. | 02 Jun 2022 | 100,000 | 1,242,797 | - | 19.6 | 1,955,000 | Common Stock |
| Cynthia Collins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 9,067 | 9,067 | - | - | Restricted Stock Units | |
| Mason P. Slaine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 9,067 | 9,067 | - | - | Restricted Stock Units | |
| Matthew M. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 9,067 | 9,067 | - | - | Restricted Stock Units | |
| James E. Cashman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 9,067 | 9,067 | - | - | Restricted Stock Units | |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 9,067 | 9,067 | - | - | Restricted Stock Units | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 109,740 | 109,740 | - | - | Restricted Stock Units | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 9,255 | 2,168,796 | - | 21.5 | 198,797 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 1,982 | 226,723 | - | 21.5 | 42,573 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 25,939 | 25,939 | - | - | Restricted Stock Units | |
| Robert Aspbury | PRESIDENT, SIMCYP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 25,939 | 25,939 | - | - | Restricted Stock Units | |
| Robert Aspbury | PRESIDENT, SIMCYP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 2,870 | 276,099 | - | 21.5 | 61,648 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 2,326 | 394,764 | - | 21.5 | 49,962 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 25,939 | 25,939 | - | - | Restricted Stock Units | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 19,953 | 19,953 | - | - | Restricted Stock Units | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 1,723 | 209,564 | - | 21.5 | 37,010 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 1,914 | 248,577 | - | 21.5 | 41,113 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 15,962 | 15,962 | - | - | Restricted Stock Units | |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 39,906 | 39,906 | - | - | Restricted Stock Units | |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 3,973 | 492,870 | - | 21.5 | 85,340 | Common Stock |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 11,972 | 11,972 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 22.29 per share. | 01 Apr 2022 | 3,352 | 98,490 | - | 22.3 | 74,716 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 25,939 | 25,939 | - | - | Restricted Stock Units | |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 01 Apr 2022 | 1,532 | 101,842 | - | 21.5 | 32,907 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 16 Mar 2022 | 125,000 | 1,342,797 | - | 20.3 | 2,531,250 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 20.17 per share. | 16 Mar 2022 | 125,000 | 1,467,797 | - | 20.2 | 2,521,250 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.17 per share. | 16 Mar 2022 | 62,485 | 2,178,051 | - | 20.2 | 1,260,322 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 16 Mar 2022 | 3,000 | 211,287 | - | 20 | 60,000 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 11 Mar 2022 | 27,515 | 2,240,536 | - | 20.3 | 558,279 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 23.93 per share. | 18 Feb 2022 | 4,706 | 2,268,051 | - | 23.9 | 112,615 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 23.31 per share. | 18 Feb 2022 | 70,294 | 2,272,757 | - | 23.3 | 1,638,553 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 24.93 per share. | 17 Feb 2022 | 30,075 | 2,349,569 | - | 24.9 | 749,770 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.49 per share. | 17 Feb 2022 | 6,518 | 2,343,051 | - | 25.5 | 166,144 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 23.83 per share. | 17 Feb 2022 | 53,407 | 2,379,644 | - | 23.8 | 1,272,689 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 26.80 per share. | 01 Feb 2022 | 14,801 | 1,592,797 | - | 26.8 | 396,667 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 26.53 per share. | 01 Feb 2022 | 35,199 | 1,607,598 | - | 26.5 | 933,829 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 24.72 per share. | 26 Jan 2022 | 23,804 | 2,484,247 | - | 24.7 | 588,435 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.67 per share. | 26 Jan 2022 | 51,196 | 2,433,051 | - | 25.7 | 1,314,201 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 26.01 per share. | 26 Jan 2022 | 3,000 | 214,287 | - | 26.0 | 78,030 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 20 Jan 2022 | 5,000 | 397,090 | - | 27.5 | 137,500 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 28.57 per share. | 03 Jan 2022 | 40,323 | 1,652,474 | - | 28.6 | 1,152,028 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 28.88 per share. | 03 Jan 2022 | 9,677 | 1,642,797 | - | 28.9 | 279,472 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 29.30 per share. | 27 Dec 2021 | 3,000 | 222,287 | - | 29.3 | 87,900 | Common Stock |
| James E. Cashman | Director | Sale of securities on an exchange or to another person at price $ 29.20 per share. | 23 Dec 2021 | 25,111 | 438,782 | - | 29.2 | 733,241 | Common Stock |
| James E. Cashman | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 22 Dec 2021 | 19,889 | 463,893 | - | 29 | 576,781 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 28.58 per share. | 22 Dec 2021 | 75,000 | 2,508,051 | - | 28.6 | 2,143,500 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 20 Dec 2021 | 7,500 | 250,491 | - | 28 | 210,000 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 26.13 per share. | 17 Dec 2021 | 5,000 | 257,991 | - | 26.1 | 130,650 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 28.55 per share. | 13 Dec 2021 | 100 | 1,692,797 | - | 28.6 | 2,855 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 28.05 per share. | 13 Dec 2021 | 49,900 | 1,692,897 | - | 28.1 | 1,399,695 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 07 Dec 2021 | 54,849 | 2,583,051 | - | 27.8 | 1,525,899 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 27.58 per share. | 07 Dec 2021 | 15,151 | 2,637,900 | - | 27.6 | 417,865 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.54 per share. | 03 Dec 2021 | 3,500 | 2,653,051 | - | 26.5 | 92,890 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.99 per share. | 03 Dec 2021 | 66,500 | 2,656,551 | - | 26.0 | 1,728,335 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 28.40 per share. | 24 Nov 2021 | 127,521 | 2,740,530 | - | 28.4 | 3,621,596 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 28.66 per share. | 24 Nov 2021 | 17,479 | 2,723,051 | - | 28.7 | 500,948 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 29.74 per share. | 22 Nov 2021 | 376,149 | 1,742,797 | - | 29.7 | 11,187,047 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 30.31 per share. | 19 Nov 2021 | 70,000 | 2,868,051 | - | 30.3 | 2,121,700 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 30.30 per share. | 19 Nov 2021 | 20,000 | 262,991 | - | 30.3 | 606,000 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 37.85 per share. | 15 Nov 2021 | 14,700 | 230,587 | - | 37.9 | 556,395 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 38.56 per share. | 15 Nov 2021 | 700 | 248,287 | - | 38.6 | 26,992 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 37.84 per share. | 15 Nov 2021 | 49,300 | 248,987 | - | 37.8 | 1,865,512 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 38.96 per share. | 15 Nov 2021 | 5,000 | 225,287 | - | 39.0 | 194,800 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 38.66 per share. | 15 Nov 2021 | 300 | 230,287 | - | 38.7 | 11,598 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 38.96 per share. | 15 Nov 2021 | 3,000 | 245,287 | - | 39.0 | 116,880 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.83 per share. | 15 Nov 2021 | 65,896 | 497,613 | - | 37.8 | 2,492,846 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.57 per share. | 15 Nov 2021 | 770 | 496,843 | - | 38.6 | 29,699 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 11 Nov 2021 | 4,592 | 278,969 | - | 40.1 | 183,956 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 39.43 per share. | 11 Nov 2021 | 16,962 | 283,561 | - | 39.4 | 668,812 | Common Stock |
| Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 3,631 | 103,374 | - | 0 | Common Stock | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 39.24 per share. | 27 Oct 2021 | 74,800 | 2,938,251 | - | 39.2 | 2,935,152 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 39.76 per share. | 27 Oct 2021 | 200 | 2,938,051 | - | 39.8 | 7,952 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 39.95 per share. | 26 Oct 2021 | 3,000 | 402,090 | - | 40.0 | 119,850 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 39.95 per share. | 26 Oct 2021 | 3,000 | 298,287 | - | 40.0 | 119,850 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 38.60 per share. | 21 Oct 2021 | 6,116 | 405,090 | - | 38.6 | 236,078 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 38.58 per share. | 20 Oct 2021 | 12,674 | 411,206 | - | 38.6 | 488,963 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 38.55 per share. | 19 Oct 2021 | 1,210 | 423,880 | - | 38.6 | 46,646 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 38.56 per share. | 19 Oct 2021 | 483 | 282,991 | - | 38.6 | 18,624 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 38.15 per share. | 19 Oct 2021 | 18,083 | 283,474 | - | 38.1 | 689,866 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 37.05 per share. | 19 Oct 2021 | 1,434 | 301,557 | - | 37.1 | 53,130 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.33 per share. | 18 Oct 2021 | 4,618 | 563,509 | - | 37.3 | 172,390 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 36.42 per share. | 18 Oct 2021 | 62,049 | 568,127 | - | 36.4 | 2,259,825 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 37.38 per share. | 15 Oct 2021 | 5,000 | 425,090 | - | 37.4 | 186,900 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 37.38 per share. | 15 Oct 2021 | 5,000 | 301,287 | - | 37.4 | 186,900 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 01 Oct 2021 | 2,767 | 300,523 | - | 34.2 | 94,742 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 33.39 per share. | 01 Oct 2021 | 16,587 | 303,290 | - | 33.4 | 553,840 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 27 Sep 2021 | 3,000 | 430,090 | - | 36 | 108,000 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 27 Sep 2021 | 3,000 | 306,287 | - | 36 | 108,000 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 36.83 per share. | 22 Sep 2021 | 16,854 | 3,013,051 | - | 36.8 | 620,733 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 36.24 per share. | 22 Sep 2021 | 58,146 | 3,029,905 | - | 36.2 | 2,107,211 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.03 per share. | 20 Sep 2021 | 18,570 | 630,176 | - | 35.0 | 650,507 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 34.46 per share. | 20 Sep 2021 | 48,097 | 648,746 | - | 34.5 | 1,657,423 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 35.32 per share. | 17 Sep 2021 | 6,265 | 316,726 | - | 35.3 | 221,280 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 35.96 per share. | 17 Sep 2021 | 13,735 | 302,991 | - | 36.0 | 493,911 | Common Stock |
| Mason P. Slaine | Director | Sale of securities on an exchange or to another person at price $ 29.80 per share. | 13 Sep 2021 | 620,668 | 2,118,946 | - | 29.8 | 18,495,286 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Sale of securities on an exchange or to another person at price $ 32.40 per share. | 09 Sep 2021 | 6,241 | 273,687 | - | 32.4 | 202,208 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Sale of securities on an exchange or to another person at price $ 36.10 per share. | 09 Sep 2021 | 500 | 228,705 | - | 36.1 | 18,050 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Sale of securities on an exchange or to another person at price $ 35.25 per share. | 09 Sep 2021 | 24,085 | 229,205 | - | 35.2 | 848,996 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Sale of securities on an exchange or to another person at price $ 34.50 per share. | 09 Sep 2021 | 15,447 | 253,290 | - | 34.5 | 532,922 | Common Stock |
| Leif E. Pedersen | PRESIDENT, SOFTWARE | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 09 Sep 2021 | 4,950 | 268,737 | - | 33.4 | 165,231 | Common Stock |
| Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 34.15 per share. | 02 Sep 2021 | 1,900 | 364,672 | - | 34.2 | 64,885 | Common Stock |
| Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 37.21 per share. | 02 Sep 2021 | 200 | 316,010 | - | 37.2 | 7,442 | Common Stock |
| Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 36.64 per share. | 02 Sep 2021 | 48,462 | 316,210 | - | 36.6 | 1,775,648 | Common Stock |
| Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 33.51 per share. | 02 Sep 2021 | 3,900 | 366,572 | - | 33.5 | 130,689 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 01 Sep 2021 | 800 | 319,877 | - | 34.2 | 27,392 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 33.76 per share. | 01 Sep 2021 | 18,554 | 320,677 | - | 33.8 | 626,383 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 33.66 per share. | 01 Sep 2021 | 19,409 | 319,878 | - | 33.7 | 653,307 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 01 Sep 2021 | 10,591 | 309,287 | - | 34.1 | 360,729 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 33.50 per share. | 30 Aug 2021 | 9,000 | 433,090 | - | 33.5 | 301,500 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 31.37 per share. | 25 Aug 2021 | 50,692 | 3,088,051 | - | 31.4 | 1,590,208 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 31.08 per share. | 25 Aug 2021 | 24,308 | 3,138,743 | - | 31.1 | 755,493 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 24 Aug 2021 | 7,500 | 322,991 | - | 30 | 225,000 | Common Stock |
| Jieun W. Choe | CHIEF STRATEGY & MARKETING | Sale of securities on an exchange or to another person at price $ 28.34 per share. | 19 Aug 2021 | 12,500 | 330,491 | - | 28.3 | 354,250 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 28.58 per share. | 16 Aug 2021 | 5,000 | 442,090 | - | 28.6 | 142,900 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 28.58 per share. | 16 Aug 2021 | 8,000 | 339,287 | - | 28.6 | 228,640 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.90 per share. | 16 Aug 2021 | 1,400 | 696,843 | - | 28.9 | 40,460 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.21 per share. | 16 Aug 2021 | 65,267 | 698,243 | - | 28.2 | 1,841,182 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 11 Aug 2021 | 19,354 | 339,231 | - | 27.5 | 533,009 | Common Stock |
| Nancy Killefer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2021 | 6,431 | 6,431 | - | 0 | Common Stock | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2021 | 5,513 | 15,620 | - | 0 | Common Stock | |
| Nicolette D. Sherman | CHIEF HUMAN RESOURCES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2021 | 10,107 | 10,107 | - | 0 | Common Stock | |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.16 per share. | 28 Jul 2021 | 75,000 | 3,163,051 | - | 26.2 | 1,962,000 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 26.27 per share. | 26 Jul 2021 | 3,000 | 347,287 | - | 26.3 | 78,810 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 01 Jul 2021 | 19,354 | 358,585 | - | 28.0 | 542,493 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 5,495 | 377,939 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 28.38 per share. | 28 Jun 2021 | 3,000 | 350,287 | - | 28.4 | 85,140 | Common Stock |
| Richard M. Traynor | SVP AND GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 26.37 per share. | 24 Jun 2021 | 5,000 | 353,287 | - | 26.4 | 131,850 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.53 per share. | 23 Jun 2021 | 74,800 | 3,238,251 | - | 26.5 | 1,984,444 | Common Stock |
| William F. Feehery | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 27.17 per share. | 23 Jun 2021 | 200 | 3,238,051 | - | 27.2 | 5,434 | Common Stock |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.94 per share. | 22 Jun 2021 | 66,666 | 830,177 | - | 26.9 | 1,795,982 | Common Stock |
| Justin Edge | PRES., REGULATORY & ACCESS | Sale of securities on an exchange or to another person at price $ 27.02 per share. | 16 Jun 2021 | 5,000 | 447,090 | - | 27.0 | 135,075 | Common Stock |
| Carol G. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 7,059 | 7,059 | - | 0 | Common Stock | |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 28.11 per share. | 14 Jun 2021 | 3,007 | 372,444 | - | 28.1 | 84,527 | Common Stock |
| Robert Aspbury | PRESIDENT, SIMCYP | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 14 Jun 2021 | 16,347 | 375,451 | - | 27.5 | 449,379 | Common Stock |
| Mason P. Slaine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 7,059 | 2,739,614 | - | 0 | Common Stock | |
| Matthew M. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 7,059 | 179,960 | - | 0 | Common Stock | |
| Sherilyn S. McCoy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 7,059 | 621,143 | - | 0 | Common Stock | |
| James E. Cashman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 7,059 | 483,782 | - | 0 | Common Stock | |
| William F. Feehery | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 91,575 | 3,313,051 | - | 0 | Common Stock | |
| Leif E. Pedersen | President, Software | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 23,810 | 279,928 | - | 0 | Common Stock | |
| Robert Aspbury | President, Simcyp | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 18,315 | 391,798 | - | 0 | Common Stock | |
| Justin Edge | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 23,810 | 452,090 | - | 0 | Common Stock | |
| Craig R. Rayner | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 23,810 | 464,744 | - | 0 | Common Stock | |
| Richard M. Traynor | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 16,484 | 358,287 | - | 0 | Common Stock | |
| Jieun W. Choe | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 18,315 | 342,991 | - | 0 | Common Stock | |
| Judith Dickinson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 11,905 | 173,564 | - | 0 | Common Stock | |
| Michael Andrew Schemick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 34,799 | 896,843 | - | 0 | Common Stock | |
| Stephen M. McLean | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 15 Dec 2020 | 22,000 | 22,000 | - | 23 | 506,000 | Common Stock |
| Matthew M. Walsh | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 10 Dec 2020 | 5,000 | 172,901 | - | 23 | 115,000 | Common Stock |
| Matthew M. Walsh | Director | Other type of transaction at price $ 0.00 per share. | 10 Dec 2020 | 22,304 | 22,304 | - | - | Common Stock | |
| Matthew M. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 145,597 | 167,901 | - | - | Common Stock | |
| James E. Cashman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 137,779 | 456,723 | - | - | Common Stock | |
| James E. Cashman | Director | Other type of transaction at price $ 0.00 per share. | 10 Dec 2020 | 318,944 | 318,944 | - | - | Common Stock | |
| James E. Cashman | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 10 Dec 2020 | 20,000 | 476,723 | - | 23 | 460,000 | Common Stock |
| Richard M. Traynor | SVP and General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Dec 2020 | 117,525 | 117,525 | - | - | Common Stock | |
| Richard M. Traynor | SVP and General Counsel | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 10 Dec 2020 | 245 | 341,803 | - | 23 | 5,635 | Common Stock |
| Richard M. Traynor | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 224,033 | 341,558 | - | - | Common Stock | |
| Michael Andrew Schemick | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.37 per share. | 19 Jul 2019 | 66,667 | 763,510 | - | 24.4 | 1,624,675 | Common Stock |